RAC1 and cardiac hypertrophy: In another rat model of HFpEF (transgenic rats overexpressing the renin gene with elevated cardiac levels of angiotensin II), rosuvastatin significantly reduced Rac1 expression, cardiac hypertrophy, and perivascular fibrosis, and improved LV contractility [126].